scholarly article | Q13442814 |
P50 | author | Christine Miaskowski | Q61448594 |
P2093 | author name string | Janice S Lee | |
Jon D Levine | |||
Steven M Paul | |||
Robert W Gear | |||
Mehran Hossaini-Zadeh | |||
Newton C Gordon | |||
P2860 | cites work | The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain | Q28146053 |
Nalbuphine is better than naloxone for treatment of side effects after epidural morphine | Q28316938 | ||
Sex differences in opioid analgesia: clinical and experimental findings. | Q35868750 | ||
Comparison of intravenous nalbuphine infusion versus naloxone in the prevention of epidural morphine-related side effects | Q39444357 | ||
Pharmacological mechanisms of opioid analgesics. | Q39496101 | ||
Pharmacology of opioids. | Q40093863 | ||
Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene | Q41157124 | ||
Biochemical and pharmacological evidence for opioid receptor multiplicity in the central nervous system | Q41558964 | ||
Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic | Q44342297 | ||
Gender difference in analgesic response to the kappa-opioid pentazocine | Q44343402 | ||
Sexual dimorphism in very low dose nalbuphine postoperative analgesia | Q44346443 | ||
Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor. | Q44349908 | ||
Synergism between the analgesic actions of morphine and pentazocine | Q44573693 | ||
Dose ratio is important in maximizing naloxone enhancement of nalbuphine analgesia in humans | Q44612830 | ||
Enhancement of morphine analgesia by the GABAB agonist baclofen | Q46087692 | ||
Kappa-opioids produce significantly greater analgesia in women than in men. | Q46134239 | ||
Differences in postoperative pain severity among four ethnic groups | Q46520182 | ||
Prevention of epidural morphine-induced respiratory depression with intravenous nalbuphine infusion in post-thoracotomy patients. | Q51750056 | ||
Influence of the method of drug administration on analgesic response | Q59049891 | ||
Ceiling effect for respiratory depression by nalbuphine | Q71140984 | ||
Opioid antagonist adjuncts to epidural morphine for postcesarean analgesia: maternal outcomes | Q72543795 | ||
P433 | issue | 4 | |
P921 | main subject | postoperative pain | Q2913956 |
P304 | page(s) | 337-341 | |
P577 | publication date | 2008-01-16 | |
P1433 | published in | The Journal of Pain | Q15733728 |
P1476 | title | A subanalgesic dose of morphine eliminates nalbuphine anti-analgesia in postoperative pain | |
P478 | volume | 9 |
Q35884913 | Effects of combined opioids on pain and mood in mammals. |
Q34574523 | Evaluation of menstrual cycle effects on morphine and pentazocine analgesia |
Q37356480 | Gender differences and pain medication |
Q89586637 | Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism |
Q34144003 | Sex differences in kappa opioid pharmacology |
Q37180957 | Sex, gender, and pain: a review of recent clinical and experimental findings |
Search more.